Summit Therapeutics
SMMT
#1886
Rank
โ‚น989.26 B
Marketcap
โ‚น1,329
Share price
-5.97%
Change (1 day)
-23.16%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น17.64 Billion

According to Summit Therapeutics 's latest financial reports the company has โ‚น17.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2014 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น33.34 B415.62%
2023-12-31$โ‚น6.46 B-38.29%
2022-12-31$โ‚น10.48 B69.07%
2021-12-31$โ‚น6.19 B6.68%
2020-12-31$โ‚น5.81 B
2019-01-31$โ‚น3.96 B-1494.59%
2018-01-31$-โ‚น0.29 Billion-23.13%
2017-01-31$-โ‚น0.38 Billion-123.81%
2016-01-31$โ‚น1.55 B-26.9%
2015-01-31$โ‚น2.12 B334.5%
2014-01-31$โ‚น0.48 B29.07%
2013-01-31$โ‚น0.37 B21.72%
2012-01-31$โ‚น0.31 B-26.23%
2011-01-31$โ‚น0.42 B-56.73%
2010-01-31$โ‚น0.97 B13.24%
2009-01-31$โ‚น0.86 B-79.63%
2008-01-31$โ‚น4.23 B22.11%
2007-01-31$โ‚น3.46 B89.88%
2006-01-31$โ‚น1.82 B-16.36%
2005-01-31$โ‚น2.18 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น121.15 B 586.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น20.34 B 15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น8.05 B-54.35%๐Ÿ‡บ๐Ÿ‡ธ USA